Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

This study has been completed.
Information provided by (Responsible Party):
ChemoCentryx Identifier:
First received: October 4, 2011
Last updated: December 12, 2014
Last verified: December 2014